资源类型：
会议/期刊
收录情况：
◇ SCIE
文章类型：
会议摘要
作者：
Chen, H.[1]
*
;
Wu, Y. -L.[1]
;
Huang, Z.[2]
;
Sun, L.[3]
;
Li, X.[4]
;
Chen, L.[5]
;
Li, J.[6,22]
;
Zhu, Z.[7]
;
Zhuang, W.[8]
;
Lu, K.[9]
;
Zhang, Y.[10]
;
Wang, K.[11]
;
Chen, Y.[12]
;
Huang, D.[13]
;
Zhao, J.[14]
;
He, Y.[15]
;
Zhang, P.[16]
;
Meng, X.[17]
;
Du, Y.[18]
;
Guo, Y.[19]
;
Dong, X.[20]
;
Liu, A.[21]
;
Li, J.[6,22]
;
Cang, S.[23]
;
Wang, Q.[24]
;
Fang, T.[24]
;
Dai, H.[24]
;
Yao, S.[24]
;
Shi, Q.[24]
;
Yang, J.[24]
;
机构：
[1]Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangzhou, Peoples R China
广东省人民医院
[2]Zhejiang Canc Hosp, Hangzhou, Peoples R China
浙江省肿瘤医院
[3]Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[4]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[5]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[6]Sichuan Canc Hosp & Inst, Chengdu, Peoples R China
四川省肿瘤医院
[7]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[8]Fujian Canc Hosp, Fuzhou, Peoples R China
[9]Jiangsu Prov Hosp, Nanjing, Peoples R China
江苏省人民医院
[10]Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China
[11]Sichuan Univ, West China Hosp, Chengdu, Peoples R China
四川大学华西医院
[12]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
[13]Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
[14]Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Canc Hosp & Inst, Beijing, Peoples R China
[15]Army Med Ctr PLA, Chongqing, Peoples R China
[16]Shanghai Pulm Hosp, Shanghai, Peoples R China
[17]Shandong First Med Univ, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[18]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
[19]Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
中山大学附属第一医院
[20]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
华中科技大学同济医学院附属协和医院
[21]Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China
[22]Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China
[23]Henan Prov Peoples Hosp, Zhengzhou, Peoples R China
[24]CStone Pharmaceut Zhou Co Ltd, Suzhou, Peoples R China
出处：
JOURNAL OF THORACIC ONCOLOGY.2024,19(10):S74-S74.
ISSN：
1556-0864
关键词：
Lorlatinib
ROS1
NSCLC
WOS：
WOS:001337925600123
中科院(CAS)分区：
最新[2023]版：
大类
|
1 区
医学
小类
|
1 区
肿瘤学
1 区
呼吸系统
JCR分区：
最新[2023]版：
Q1
ONCOLOGY
Q1
RESPIRATORY SYSTEM
影响因子：
21.1
最新[2023版]
16.5
最新五年平均
21.1
出版当年[2023版]
0
出版当年五年平均
21.1
出版前一年[2023版]
第一作者：
Chen, H.
第一作者机构：
[1]Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714)：
Chen H.,Wu Y. -L.,Huang Z.,et al.A Phase II Study of Lorlatinib in Advanced ROS1+NSCLC Pre-Treated with Crizotinib and PlatinumBased Chemotherapy[J].JOURNAL OF THORACIC ONCOLOGY.2024,19(10):S74-S74.
APA：
Chen, H.,Wu, Y. -L.,Huang, Z.,Sun, L.,Li, X....&Yang, J..(2024).A Phase II Study of Lorlatinib in Advanced ROS1+NSCLC Pre-Treated with Crizotinib and PlatinumBased Chemotherapy.JOURNAL OF THORACIC ONCOLOGY,19,(10)
MLA：
Chen, H.,et al."A Phase II Study of Lorlatinib in Advanced ROS1+NSCLC Pre-Treated with Crizotinib and PlatinumBased Chemotherapy".JOURNAL OF THORACIC ONCOLOGY 19..10(2024):S74-S74
医学